‘Anyone with a Heart’ Campaign Spreads Awareness About Hereditary ATTR Amyloidosis
source: pixabay.com

‘Anyone with a Heart’ Campaign Spreads Awareness About Hereditary ATTR Amyloidosis

Fredericksburg, Virginia resident Johnny Boatman is a former national guardsman who had been in excellent physical condition all his life. That was until 2022 when he felt a sharp pain…

Continue Reading ‘Anyone with a Heart’ Campaign Spreads Awareness About Hereditary ATTR Amyloidosis
Investigational Therapy Earns Orphan Drug Designation for Hereditary Angioedema
source: shutterstock.com

Investigational Therapy Earns Orphan Drug Designation for Hereditary Angioedema

According to a story from Business Wire, the biopharmaceutical company Astria Therapeutics, Inc., recently announced that its experimental therapy navenibart has earned the US Food and Drug Administration's Orphan Drug…

Continue Reading Investigational Therapy Earns Orphan Drug Designation for Hereditary Angioedema
The Ripple Effect of My Colorectal Cancer Journey: How One Small Moment Can Change Your Life
source: pixabay.com

The Ripple Effect of My Colorectal Cancer Journey: How One Small Moment Can Change Your Life

Written by Yla Flores Have you ever experienced a seemingly small moment that ended up changing your life forever? Whether it’s turning left instead of right, going out one night…

Continue Reading The Ripple Effect of My Colorectal Cancer Journey: How One Small Moment Can Change Your Life
Study: Tirzepatide Lowers Risk of Pancreatitis and Diabetic Retinopathy vs GLP-1s
source: shutterstock.com

Study: Tirzepatide Lowers Risk of Pancreatitis and Diabetic Retinopathy vs GLP-1s

According to a story from Healio, analysis of the FDA Adverse Events Reporting System database indicates that tirzepatide has a superior safety profile when compared to GLP-1 inhibitors that have…

Continue Reading Study: Tirzepatide Lowers Risk of Pancreatitis and Diabetic Retinopathy vs GLP-1s